These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12801222)

  • 1. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new on CDC25 phosphatase inhibitors.
    Contour-Galcera MO; Sidhu A; Prévost G; Bigg D; Ducommun B
    Pharmacol Ther; 2007 Jul; 115(1):1-12. PubMed ID: 17531323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
    J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc25 phosphatases: structure, specificity, and mechanism.
    Rudolph J
    Biochemistry; 2007 Mar; 46(12):3595-604. PubMed ID: 17328562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction.
    Sohn J; Rudolph J
    Biochemistry; 2003 Sep; 42(34):10060-70. PubMed ID: 12939134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
    Lavecchia A; Di Giovanni C; Novellino E
    Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic small molecule Cdc25 phosphatases inhibitors.
    Garuti L; Roberti M; Pizzirani D
    Curr Med Chem; 2008; 15(6):573-80. PubMed ID: 18336271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
    Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI
    Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility and inhibitor binding in cdc25 phosphatases.
    Arantes GM
    Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
    Valente S; Bana E; Viry E; Bagrel D; Kirsch G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
    Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
    Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of indeno[1,2-b]indoloquinones by MALDI-MS: a new set of potential CDC25 phosphatase inhibitors brought to light.
    Alchab F; Sibille E; Ettouati L; Bana E; Bouaziz Z; Mularoni A; Monniot E; Bagrel D; Jose J; Le Borgne M; Chaimbault P
    J Enzyme Inhib Med Chem; 2016; 31(sup3):25-32. PubMed ID: 27362889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
    Ko S; Lee W; Lee S; Park H
    J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases.
    Brault L; Denancé M; Banaszak E; El Maadidi S; Battaglia E; Bagrel D; Samadi M
    Eur J Med Chem; 2007 Feb; 42(2):243-7. PubMed ID: 17084000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.